CDISC partnered with Critical Path Institute and the PKD Foundation to build a stronger foundation for data sharing and analysis across studies for new treatments.
Public source
Publisher name
Public post
Twenty+ years ago I had the opportunity to work closely with patients suffering from kidney disease through the National Kidney Foundation. I love that I still have the…
Company
CDISC
Clear Data. Clear Impact.
- Industry
- Non-profit Organizations
- Location
- Austin, US
- Company size
- 51–200 employees
About CDISC
CDISC creates clarity in clinical research by convening a global community to develop and advance data standards of the highest quality. Required by the United States Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and adopted by the world’s leading research organizations, CDISC standards enable the accessibility, interoperability, and reusability of data. With the help of CDISC standards, the entire research community can maximize the value of data for more efficient and meaningful research that has invaluable impact on global health. CDISC is a 501(c)(3) global nonprofit charitable organization and is headquartered in Austin, Texas, with hundreds of employees, volunteers, and member organizations around the world. www.cdisc.org
See moreLatest activity
Latest activity from CDISC
9 signals
Presence & Recognition
CDISC is hosting 2026 CDISC TechniCon later this week.
Partnerships
CDISC announced an expanded collaboration with the PKD Foundation and Critical Path Institute to develop Version 2.0 of the Therapeutic Area User Guide for Polycystic Kidney Disease.
Partnerships
CDISC, the PKD Foundation, and Critical Path Institute (C-Path) are collaborating to develop PKD TAUG Version 2.0.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
PKD Foundation
PKD Foundation, Critical Path Institute (C-Path), and CDISC are expanding their collaboration to develop Version 2.0 of the Therapeutic Area User Guide for Polycystic Kidney Disease (TAUG-PKD)
Partnerships
Digital Medicine Society (DiMe)
Digital Medicine Society (DiMe) welcomed Pfizer to the Composite and Multimodal Endpoints for Pediatric Rare Disease project.
Partnerships
Medable
Medable helped 5 biopharma and CRO organizations achieve unprecedented success, including faster study starts and market-leading eCOA adherence and elevated patient and site satisfaction.
Partnerships
Medidata Solutions
Medidata Solutions partnered with Caidya to drive a new generation of AI-powered studies and a unified clinical trial experience for everyone involved.
Research & Knowledge
Pistoia Alliance